STUDY OF ALDOSTERONE BLOCKADE (EPLERENONE) IN WOMEN

女性醛固酮阻断剂（依普利农）的研究

• 批准号: 7603635
• 负责人: ARSHED A QUYYUMI
• 金额: $ 0.03万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7603635
• 关键词: Aldosterone; Angiotensins; Computer Retrieval of Information on Scientific Projects Database; Double-Blind Method; Funding; Grant; Institution; Placebo Control; Placebos; Randomized; Renin; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Woman; comparative trial; day; eplerenone; prospective

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A prospective, randomized, double blind placebo-controlled, comparative trial of eplerenone, given in the presence of a renin-angiotensin blocker. Eplerenone 25mg titrated to 50mg as tolerated per day versus placebo for four months.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 在存在肾素 - 血管紧张素阻滞剂的情况下给出的一项前瞻性，随机，双盲安慰剂对照，比较试验。 eplerenone 25mg滴定至50毫克，每天耐受性安慰剂，持续四个月。